Prudential Financial
GPCR icon

Prudential Financial’s Structure Therapeutics GPCR Stock Holding History

Prudential Financial’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-42,000
Closed -$1.57M – 2669
2023
Q3 		$1.57M Hold
42,000
– – ﹤0.01% 1512
2023
Q2 		$1.75M Hold
42,000
– – ﹤0.01% 1497
2023
Q1 		$999K Buy
+42,000
New +$987K ﹤0.01% 1745

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Prudential Financial's GPCR Position: Q4 2023 in Review

Prudential Financial sold out of Structure Therapeutics (GPCR) in Q4 2023, closing a stake of 42,000 shares — an estimated $1.57M sold.

Prudential Financial first reported a position in GPCR in Q1 2023 and held it in 3 quarters. The position peaked at $1.75M in Q2 2023. 121 funds tracked by Wall St. Rank hold GPCR as of Q4 2023.

  • Prudential Financial reported no remaining Structure Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Prudential Financial sold 42,000 Structure Therapeutics shares in Q4 2023, an estimated $1.57M.
  • Prudential Financial first reported a position in Structure Therapeutics in Q1 2023 and held it in 3 quarters.
  • Prudential Financial's Structure Therapeutics position peaked at $1.75M in Q2 2023.
  • 121 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2023.

Based on Prudential Financial's 13F filing for Q4 2023, filed 13 Feb 2024.